Prospects of targeted and immune therapies in SCLC

Lizza E. L. Hendriks*, Jessica Menis, Martin Reck

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)151-167
Number of pages17
JournalExpert review of anticancer therapy
Volume19
Issue number2
DOIs
Publication statusPublished - 1 Feb 2019

Keywords

  • Checkpoint inhibitors
  • immune therapy
  • small cell lung cancer
  • targeted therapy
  • vaccination therapy
  • CELL-LUNG-CANCER
  • ANTIBODY-DRUG CONJUGATE
  • PERSONALIZED PEPTIDE VACCINATION
  • POTENTIAL THERAPEUTIC TARGET
  • PLACEBO-CONTROLLED TRIAL
  • RANDOMIZED PHASE-II
  • REGULATORY T-CELLS
  • DOUBLE-BLIND
  • AURORA KINASE
  • OPEN-LABEL

Cite this